(Q44503960)

English

Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials

scientific article published in July 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

Jonas Abrahamsson

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Sverre O Lie

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Niels Clausen

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Erik Forestier

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Liisa Hovi

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Gudmundur Jonmundsson

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Lotta Mellander

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Göran Gustafsson

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

122

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

217-225

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a European view

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Onco

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

Acute myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

Favorable impact of the t(9;11) in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

Definition of a standard-risk group in children with AML

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04418.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2003.04418.X

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44503960&oldid=2025918670"